Showing results (1-10 of 158) with videos related to
Sort By:
Pageof 16
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 25, 2012
[Epigenomic markers for tumors]Atsushi KanedaCancer Science|March 17, 2021
Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancerAtsushi Okabe, Atsushi KanedaCancer Science|June 2, 2026
Gastric Mucosal Molecular Alterations and Multimodal Field-Based Risk Models for Gastric Cancer DevelopmentGenki Usui, Atsushi KanedaMethods in Molecular Biology (Clifton, N.J.)|September 6, 2022
Hi-C Analysis to Identify Genome-Wide Chromatin Structural Aberration in CancerAtsushi Okabe, Atsushi KanedaCancer Science|December 17, 2010
Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypesAtsushi Kaneda, Koichi YagiMethods in Molecular Biology (Clifton, N.J.)|November 26, 2014
Quantitative DNA methylation analysis for epigenotyping of colorectal cancerAtsushi Kaneda, Koichi YagiCancer Research|December 17, 2005
Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor riskAtsushi Kaneda, Andrew P FeinbergPathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 5, 2015
Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene MutationsHiroyuki Abe, Atsushi Kaneda, Masashi FukayamaAdvances in Experimental Medicine and Biology|June 14, 2018
Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric CancerMasashi Fukayama, Akiko Kunita, Atsushi KanedaWorld Journal of Gastroenterology|February 28, 2014
Accumulation of aberrant DNA methylation during colorectal cancer developmentEiji Sakai, Atsushi Nakajima, Atsushi KanedaPageof 16